Arkolith/Insider Trading/SPRO/Form 4

Mahadevia Ankit

CEO and President, DirectorSpero Therapeutics, Inc. (SPRO) · full profile →Form 4 · filed Feb 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 3, 2023Sell(S)12K$1.81$22K798K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-004039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML